Biden Kicks Off Presidency With Medicaid, Rebate Rule Actions

In a series of steps that were largely expected, the Biden administration in its early days moved to revisit policies approved by the prior administration that it views as weakening Medicaid and Affordable Care Act (ACA) coverage. At the same time, the administration delayed the implementation of an HHS final rule to eliminate rebates in Medicare Part D, giving it more time to consider the rule’s full impact and potentially amend or rescind it after a comment period.

“When it comes to health policy, the Biden administration is taking a really hard look at policies in the Medicaid and Medicare space that they view [as] significant and that they want to make sure are in line with their view…[including] looking at the larger rules that impact a space like the rebate rule,” observes Stephanie Kennan, a member of McGuireWoods Consulting’s federal public affairs group and former senior health policy adviser to Sen. Ron Wyden (D-Ore.).

© 2025 MMIT
Lauren Flynn Kelly

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Lauren has been covering health business issues since the early 2000s and specializes in in-depth reporting on Medicare Advantage, managed Medicaid and Medicare Part D. She also possesses a deep understanding of the complex world of pharmacy benefit management, having written AIS Health’s Radar on Drug Benefits from 2004 to 2005 and again from 2011 to 2016. In addition to her role as managing editor of Radar on Medicare Advantage, she oversees AIS Health’s publications and manages the health editorial staff. She graduated from Vassar College with a B.A. in English.

Related Posts

unitedhealthcare-headquarters
October 3

UnitedHealthcare, Humana Nab Half of $11.8B in 2024 Quality Bonus Payments

READ MORE
stock-chart
October 3

’25 Stars Info Spooks Humana Investors, Stokes Fears About Industry Decline

READ MORE
elderly-woman-looking-at-ipad
October 3

Minn. Blues Plan’s Value-Based Pact With Herself Health Focuses on Senior Women

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today